. . . . . "CZ - \u010Cesk\u00E1 republika" . . . "Cor et Vasa" . "technical aspec; safety; renal denervation; complication"@en . . "Technical and safety aspects of renal denervation" . . "I" . "RIV/00216208:11120/14:43908332" . "4"^^ . "RIV/00216208:11120/14:43908332!RIV15-MSM-11120___" . "10.1016/j.crvasa.2014.02.004" . . "49421" . "\u010Curila, Karol" . . "[AA965B83C13D]" . "0010-8650" . "Aims: Renal denervation is a novel method used to treat patients with resistant hypertension. Several studies showing the efficacy of this method in blood pressure reduction have been published. However, there is a lack of data that focused on the technical aspects of the procedure. The aim of this paper is to present and discuss the technical and safety issues of the procedure. Methods and results: 37 patients underwent renal denervation using a Symplicity catheter between 10/2011 and 8/2013. Number of ablations, procedural time, consumption of contrast agent and complication rate during hospitalization were recorded. Bilateral denervation was performed on 35 patients; in 29 of the cases, at least 4 ablations in each renal artery were done. The average duration of procedure was 57 \u00B1 10 min and the average amount of contrast agent used was 93 \u00B1 29 ml. During the study, both values were trending downward as the numbers of procedures increased. We observed minor complications in 9 patients. None of them were serious and none resulted in patient disability. Conclusion: Renal denervation is for skilled interventional cardiologist an easy and safe method with a short learning curve. It may be accompanied by minor complications, not deteriorating patient health status."@en . "Technical and safety aspects of renal denervation"@en . "Technical and safety aspects of renal denervation"@en . "Widimsk\u00FD, Petr" . "11120" . . "Rosa, J\u00E1n" . . "Aims: Renal denervation is a novel method used to treat patients with resistant hypertension. Several studies showing the efficacy of this method in blood pressure reduction have been published. However, there is a lack of data that focused on the technical aspects of the procedure. The aim of this paper is to present and discuss the technical and safety issues of the procedure. Methods and results: 37 patients underwent renal denervation using a Symplicity catheter between 10/2011 and 8/2013. Number of ablations, procedural time, consumption of contrast agent and complication rate during hospitalization were recorded. Bilateral denervation was performed on 35 patients; in 29 of the cases, at least 4 ablations in each renal artery were done. The average duration of procedure was 57 \u00B1 10 min and the average amount of contrast agent used was 93 \u00B1 29 ml. During the study, both values were trending downward as the numbers of procedures increased. We observed minor complications in 9 patients. None of them were serious and none resulted in patient disability. Conclusion: Renal denervation is for skilled interventional cardiologist an easy and safe method with a short learning curve. It may be accompanied by minor complications, not deteriorating patient health status." . "56" . "5"^^ . . "3" . . "7"^^ . . . "Technical and safety aspects of renal denervation" . . "Tou\u0161ek, Petr" .